Role of clinical pharmacist in the management of blood pressure in dialysis patients
- 18 May 2016
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (4) , 931-940
Abstract
Background Hypertension is highly prevalent yet undertreated condition in hemodialysis patients. Objective The objective of this study was to evaluate clinical pharmacist’s role in the management of blood pressure in hemodialysis patients guided by home blood pressure monitoring. Setting Outpatient hemodialysis units of Jordan University Hospital and Isra’a Hospital. Method This was a randomized controlled study. It lasted 6 months (September 2011 till the end of March 2012). All hypertensive patients receiving hemodialysis were invited to participate in the study. Out of 60 patients approached, 56 were actually included. Patients were randomly allocated to an intervention (29) or control group (27). In the intervention arm, patients received physician-pharmacist collaborative care. While in the control arm patients received standard medical care. Main outcome measure Percentage of patients achieving weekly average home blood pressure below or equal 135/85 mmHg. Other secondary measures that were assessed include absolute reduction in peridialysis blood pressure, interdialytic weight gain, adherence to medications and dialysis sessions. Results A total of 52 patients completed the study. Forty-six percent of patients in the intervention arm achieved BP target (mean home blood pressure ≤135/85 mmHg) compared to only 14.3 % of patients in the control arm (p = 0.02). Average decline in weekly mean home systolic blood pressure was 10.9 ± 17.7 mmHg in the intervention arm (p = 0.004), while weekly mean home systolic blood pressure increased by 3.5 ± 18.4 mmHg in the control arm (p = 0.396). No significant reduction was achieved in weekly home diastolic blood pressure, dialysis blood pressure readings, or interdialytic weight gain in either arm. Conclusions Clinical pharmacist-physicians’ collaboration improved rate of blood pressure control in hemodialysis patients. Using home blood pressure monitoring was found to be an efficient way to guide blood pressure therapy.Keywords
Funding Information
- the University of Jordan
This publication has 25 references indexed in Scilit:
- Implementation of clinical pharmacy services in a pediatric dialysis unitPediatric Nephrology, 2014
- Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patientsCurrent Opinion in Nephrology and Hypertension, 2011
- Toward a Definition of Masked Hypertension and White-Coat Hypertension among Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- A Randomized Controlled Trial to Assess Pharmacist-Physician Collaborative Practice in the Management of Metabolic Syndrome in a University Medical Clinic in JordanJournal of Managed Care Pharmacy, 2011
- Pharmacist-physician collaboration improves blood pressure controlSaudi Medical Journal, 2011
- Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysisAmerican Journal of Health-System Pharmacy, 2011
- Blood Pressure and Mortality Among Hemodialysis PatientsHypertension, 2010
- Home Blood Pressures Are of Greater Prognostic Value than Hemodialysis Unit RecordingsClinical Journal of the American Society of Nephrology, 2007
- K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.2005
- Prediction of hypertension in chronic hemodialysis patientsKidney International, 2001